CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors
Rhea-AI Summary
China Infrastructure Construction Corp. (CHNC) has enhanced its distribution strategy for educational digital content, now available on major platforms like Amazon, Walmart, and Barnes & Noble. This move follows a significant increase in its subscriber base from 50,000 to over 2 million across 109 countries. The company aims to provide comprehensive cannabis education through its platform, Pharmacology University, and has collaborated with 30 online educational companies. The digital products are offered in various languages, highlighting the company’s commitment to global outreach.
AI-generated analysis. Not financial advice.
Positive
- Expanded distribution strategy enhances accessibility of digital content on major platforms.
- Subscriber base grew from 50,000 to over 2 million in 109 countries, indicating strong demand.
- Collaboration with 30 educational companies enhances content outreach and engagement.
Negative
- None.
News Market Reaction – CHNC
On the day this news was published, CHNC gained 2.04%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Digital Content Now Available on Amazon, Walmart, Barnes & Noble, Kobo, Sympla and Many Others
HOUSTON, TX, Sept. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – China Infrastructure Construction Corp. (dba Cannabis Bioscience International Holdings), announced today that it has dramatically bolstered the distribution strategy for its educational videos, eBooks and audiobooks by making them available for purchase on the world’s leading online retail sites such as Amazon Prime, Walmart, and Barnes & Noble. Additionally, it has partnered with approximately 30 online educational companies such as Sympla, Simpliv Learning, Teachlr, Tuellus, and others to distribute its digital content.
The company’s online cannabis educational platform, Pharmacology University, is made up of a team of professionals with expertise in the areas of medicine, science, finance, dispensary, cultivation, marketing, and design. Pharmacology University is dedicated to transforming the social stigma surrounding medicinal cannabis through education. “Our mission is to provide students with the most relevant information available so they can develop a well-rounded perspective on all aspects of the cannabis industry,” said Anne Graham, CHNC Corporate Attorney and VP of Operations. “In just a short period our subscriber base has grown from about 50,000 in 60 countries to now topping 2 million in 109 countries. That is real progress.”
“We have been working tirelessly behind the scenes to build a robust worldwide distribution network for our digital content. This momentous accomplishment marks a seminal step in our corporate evolution,” said Henry Levinski, CHNC Treasurer. “This distribution strategy makes our products more accessible to consumers via the world’s leading online platforms. Our vast library of videos, eBooks and audiobooks will now be available for rent or purchase through our retail and educational partners worldwide.”
Many of the company’s digital products, such as its Cannabis World Journals, are available in multiple languages including English, Spanish, Portuguese, Italian and Arabic, with Mandarin and Hindi coming soon. To learn more visit: https://www.chnc-hdh.com/
CHNC will host a free online chat via the Discord Platform Wednesday, 9/15/21 at 7:30 pm EST / 4:30 pm PST. The live Q/A call will feature top company executives answering questions from students, investors and anyone interested in learning more about the company.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
